Nasopharyngeal carcinoma (NPC), a malignancy that develops in the upper section of the throat behind the nose, occurs in ...

BeOne Medicines has secured approval from the European Commission (EC) for Tevimbra (tislelizumab) to be used along with ...

(NASDAQ: ONC; HKEX: 06160; SSE: 688235), a global oncology company, today announced that the European Commission has approved TEVIMBRA ® (tislelizumab), in combination with gemcitabine and cisplatin, ...

In a significant step toward improving targeted cancer therapy, researchers from Japan have developed a novel nanocarrier ...

The fluorescent labeling compound—dubbed "Sialyl Lewis Yellow"—was developed by an international team led from the Pohang University of Science and Technology in South Korea. It works by binding to ...

During a median follow-up period of 17.8 years, higher incidence rates for all cancers were generally associated with higher baseline hs-cTnT and NT-proBNP levels, especially for the highest quartiles ...

Tumour biomarkers articles from across Nature Portfolio Tumour biomarkers is a term used to describe many different potential markers of cancer development and progression. These markers can come ...